Autres langues Mydecine Innovations Group Inc.

Actions

MYCOF

CA62849F2008

Marché Fermé - OTC Markets Autres places de cotation 16:08:57 11/07/2024			Varia. 5j.	Varia. 1 janv.
0,016 ^USD	+29,76 %		+30,08 %	+7,38 %

05/07	Le Groupe Mydecine Innovations Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
02/07	Mydecine Innovations Group Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Mydecine Announces Filing of Audited and Q1 Financial Statements	05/07
Mydecine Innovations Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05/07
Mydecine Innovations Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02/07
Mydecine Provides Bi-Weekly Status Report	01/06
Mydecine Provides Bl-Weekly Status Report	17/05
Mydecine Applies for Management Cease Trade Order	03/05
Mydecine Receives Management Cease Trade Order	03/05
Mydecine Innovations Group Inc. Announces Restructuring Transactions and Annual General and Special Meeting	02/05
Mydecine Innovations Group Inc. announced that it expects to receive CAD 1 million in funding	01/05
Mydecine Announces Intention to Refile Certain Financial Statements and Applies for Management Cease Trade Order	26/04
Mydecine Innovations Group Inc. Announces Share for Debt Settlement	20/03
Mydecine Innovations Closes Partial Debt Settlement	23/02
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds	07/02
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds	07/02
Mydecine Innovations Group Announces Director Resignation	02/02
Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director	02/02
Mydecine Innovations Group Receives Notice of Allowance from USPTO For MYCO-005 Compound	18/12
Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound	18/12
Mydecine Announces Update Regarding the Special Access Program	28/11
Mydecine Innovations Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	18/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Mydecine Innovations Group Inc.

Actions

MYCOF

CA62849F2008

Autres langues

Filtres